{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:23:52Z","timestamp":1771979032450,"version":"3.50.1"},"reference-count":40,"publisher":"Radiation Research Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiation Research"],"published-print":{"date-parts":[[2021,4,29]]},"DOI":"10.1667\/rade-20-00288.1","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T12:38:10Z","timestamp":1624970290000},"source":"Crossref","is-referenced-by-count":6,"title":["Mitigation of Hematopoietic Syndrome of Acute Radiation Syndrome by 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) is Associated with Regulation of Systemic Inflammation in a Murine Model of Total-Body Irradiation"],"prefix":"10.1667","volume":"196","author":[{"given":"Yong-Jae","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Global New Drug Development, Enzychem Lifesciences, Daejeon 34013, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinseon","family":"Jeong","sequence":"additional","affiliation":[{"name":"Division of Global New Drug Development, Enzychem Lifesciences, Daejeon 34013, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaapjoo","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Global New Drug Development, Enzychem Lifesciences, Daejeon 34013, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Young","family":"Sohn","sequence":"additional","affiliation":[{"name":"Division of Global New Drug Development, Enzychem Lifesciences, Daejeon 34013, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Young","family":"Yoon","sequence":"additional","affiliation":[{"name":"Division of Global New Drug Development, Enzychem Lifesciences, Daejeon 34013, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Wha","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Biomaterials Research, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1243","reference":[{"key":"3","doi-asserted-by":"crossref","unstructured":"K Coeytaux, E Bey, D Christensen, et al.  \"PLoS One.\"  10, \"Reported radiation overexposure accidents worldwide, 1980\u20132013: A systematic review.\" e0118709 (2015)","DOI":"10.1371\/journal.pone.0118709"},{"key":"28","doi-asserted-by":"crossref","unstructured":"PA Plett, CH Sampson, HL Chua, et al.  \"Health Phys.\"  103, \"Establishing a murine model of the hematopoietic syndrome of the acute radiation syndrome.\" 343 (2012)","DOI":"10.1097\/HP.0b013e3182667309"},{"key":"27","doi-asserted-by":"crossref","unstructured":"JE Till  and EA McCulloch  \"Radiat Res.\"  14, \"A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.\" 213 (1961)","DOI":"10.2307\/3570892"},{"key":"8","doi-asserted-by":"crossref","unstructured":"VK Singh  and TM Seed  \"Drugs Today (Barc).\"  54, \"An update on sargramostim for treatment of acute radiation syndrome.\" 679 (2018)","DOI":"10.1358\/dot.2018.54.11.2899370"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Z Gluzman-Poltorak, V Vainstein, LA Basile,  \"Radiat Res.\"  184, \"Association of hematological nadirs and survival in a nonhuman primate model of hematopoietic syndrome of acute radiation syndrome.\" 226 (2015)","DOI":"10.1667\/RR13962.1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"VK Singh, PL Romaine, TM Seed,  \"Health Phys.\"  108, \"Medical countermeasures for radiation exposure and related injuries: characterization of medicines, FDA-approval status and inclusion into the Strategic National Stockpile.\" 607 (2015)","DOI":"10.1097\/HP.0000000000000279"},{"key":"22","doi-asserted-by":"crossref","unstructured":"MD Turner, B Nedjai, T Hurst, et al.  \"Biochim Biophys Acta.\"  1843, \"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease.\" 2563 (2014)","DOI":"10.1016\/j.bbamcr.2014.05.014"},{"key":"7","doi-asserted-by":"crossref","unstructured":"M Moroni, BF Ngudiankama, C Christensen, et al.  \"Int J Radiat Oncol Biol Phys.\"  86, \"The Gottingen minipig is a model of the hematopoietic acute radiation syndrome: G-colony stimulating factor stimulates hematopoiesis and enhances survival from lethal total-body gamma-irradiation.\" 986 (2013)","DOI":"10.1016\/j.ijrobp.2013.04.041"},{"key":"16","doi-asserted-by":"crossref","unstructured":"D Schaue, EL Kachikwu, WH McBride,  \"Radiat Res.\"  178, \"Cytokines in radiobiological responses: a review.\" 505 (2012)","DOI":"10.1667\/RR3031.1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"N. Dainiak,  \"J Radiat Res.\"  59, \"Medical management of acute radiation syndrome and associated infections in a high-casualty incident.\" ii54 (2018)","DOI":"10.1093\/jrr\/rry004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"S Siva, M MacManus, T Kron, et al.  \"PloS One.\"  9, \"A pattern of early radiation-induced inflammatory cytokine expression is associated with lung toxicity in patients with non-small cell lung cancer.\" e109560 (2014)","DOI":"10.1371\/journal.pone.0109560"},{"key":"4","doi-asserted-by":"crossref","unstructured":"EH Donnelly, JB Nemhauser, JM Smith, et al.  \"South Med J.\"  103, \"Acute radiation syndrome: assessment and management.\" 541 (2010)","DOI":"10.1097\/SMJ.0b013e3181ddd571"},{"key":"15","doi-asserted-by":"crossref","unstructured":"FM Di Maggio, L Minafra, GI Forte, et al.  \"J Inflamm (Lond).\"  12, \"Portrait of inflammatory response to ionizing radiation treatment.\" 14 (2015)","DOI":"10.1186\/s12950-015-0058-3"},{"key":"1","doi-asserted-by":"crossref","unstructured":"H Dorr  and V Meineke  \"BMC Med.\"  9, \"Acute radiation syndrome caused by accidental radiation exposure \u2013 therapeutic principles.\" 126 (2011)","DOI":"10.1186\/1741-7015-9-126"},{"key":"2","doi-asserted-by":"crossref","unstructured":"CJ Martin, J Vassileva, E Vano, et al.  \"J Radiol Prot.\"  37, \"Unintended and accidental medical radiation exposures in radiology: guidelines on investigation and prevention.\" 883 (2017)","DOI":"10.1088\/1361-6498\/aa881e"},{"key":"5","doi-asserted-by":"crossref","unstructured":"IGM Macia, A Lucas Calduch, EC Lopez,  \"Rep Pract Oncol Radiother.\"  16, \"Radiobiology of the acute radiation syndrome.\" 123 (2011)","DOI":"10.1016\/j.rpor.2011.06.001"},{"key":"10","doi-asserted-by":"crossref","unstructured":"C Li, L Lu, J Zhang, et al.  \"Cell Biosci.\"  5, \"Granulocyte colony-stimulating factor exacerbates hematopoietic stem cell injury after irradiation.\" 65 (2015)","DOI":"10.1186\/s13578-015-0057-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"R van Os, S Robinson, T Sheridan, et al.  \"Stem Cells.\"  18, \"Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.\" 120 (2000)","DOI":"10.1634\/stemcells.18-2-120"},{"key":"12","doi-asserted-by":"crossref","unstructured":"R van Os, S Robinson, T Sheridan, et al.  \"Blood.\"  92, \"Granulocyte colony-stimulating factor enhances bone marrow stem cell damage caused by repeated administration of cytotoxic agents.\" 1950 (1998)","DOI":"10.1182\/blood.V92.6.1950.418k21_1950_1956"},{"key":"14","doi-asserted-by":"crossref","unstructured":"HA Carvalho  and RC Villar  \"Clinics (Sao Paulo).\"  73, \"Radiotherapy and immune response: the systemic effects of a local treatment.\" e557s (2018)","DOI":"10.6061\/clinics\/2018\/e557s"},{"key":"17","doi-asserted-by":"crossref","unstructured":"HO Yang, SH Kim, SH Cho, et al.  \"Chem Pharm Bull (Tokyo).\"  52, \"Purification and structural determination of hematopoietic stem cell-stimulating monoacetyldiglycerides from Cervus nippon (deer antler).\" 874 (2004)","DOI":"10.1248\/cpb.52.874"},{"key":"18","doi-asserted-by":"crossref","unstructured":"YJ Kim, J Jeong, SH Shin, et al.  \"Radiat Res.\"  192, \"Mitigating effects of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) on hematopoietic acute radiation syndrome after total-body ionizing irradiation in mice.\" 602 (2019)","DOI":"10.1667\/RR15440.1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"J Jeong, YJ Kim, DY Lee, et al.  \"Cancers (Basel).\"  11, \"Mitigating effect of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) on a murine model of 5-fluorouracil-induced hematological toxicity.\" 1811 (2019)","DOI":"10.3390\/cancers11111811"},{"key":"20","doi-asserted-by":"crossref","unstructured":"HR Lee, N Yoo, J Jeong, et al.  \"Thromb Res.\"  161, \"PLAG alleviates chemotherapy-induced thrombocytopenia via promotion of megakaryocyte\/erythrocyte progenitor differentiation in mice.\" 84 (2018)","DOI":"10.1016\/j.thromres.2017.10.005"},{"key":"21","doi-asserted-by":"crossref","unstructured":"CA Barker, SK Kim, S Budhu, et al.  \"J Immunother Cancer.\"  6, \"Cytokine release syndrome after radiation therapy: case report and review of the literature.\" 1 (2018)","DOI":"10.1186\/s40425-017-0311-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"A Katano, W Takahashi, H Yamashita, et al.  \"Sci Rep.\"  7, \"The impact of elevated C-reactive protein level on the prognosis for oro-hypopharynx cancer patients treated with radiotherapy.\" 17805 (2017)","DOI":"10.1038\/s41598-017-18233-w"},{"key":"24","doi-asserted-by":"crossref","unstructured":"E Lee, OL Nelson, C Puyana, et al.  \"Breast Cancer Res.\"  21, \"Association between C-reactive protein and radiotherapy-related pain in a tri-racial\/ethnic population of breast cancer patients: a prospective cohort study.\" 70 (2019)","DOI":"10.1186\/s13058-019-1151-y"},{"key":"25","doi-asserted-by":"crossref","unstructured":"S Basu, A Dunn, A Ward,  \"Int J Mol Med.\"  10, \"G-CSF: function and modes of action (Review).\" 3 (2002)","DOI":"10.3892\/ijmm.10.1.3"},{"key":"26","doi-asserted-by":"crossref","unstructured":"AW. Roberts,  \"Growth Factors.\"  23, \"G-CSF: a key regulator of neutrophil production, but that's not all!\" 33 (2005)","DOI":"10.1080\/08977190500055836"},{"key":"29","doi-asserted-by":"crossref","unstructured":"J Harrold, PO Gisleskog, I Delor, et al.  \"Pharm Res.\"  37, \"Quantification of radiation injury on neutropenia and the link between absolute neutrophil count time course and overall survival in nonhuman primates treated with G-CSF.\" 102 (2020)","DOI":"10.1007\/s11095-020-02839-3"},{"key":"31","doi-asserted-by":"crossref","unstructured":"F Crea, E Giovannetti, PL Zinzani, et al.  \"Crit Rev Oncol Hematol.\"  72, \"Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization.\" 21 (2009)","DOI":"10.1016\/j.critrevonc.2008.10.014"},{"key":"32","doi-asserted-by":"crossref","unstructured":"S Kelly  and D Wheatley  \"Br J Cancer.\"  101, \"Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors.\" S6 (2009)","DOI":"10.1038\/sj.bjc.6605269"},{"key":"33","doi-asserted-by":"crossref","unstructured":"T Takeshima, LM Pop, A Laine, et al.  \"Proc Natl Acad Sci U S A.\"  113, \"Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF.\" 11300 (2016)","DOI":"10.1073\/pnas.1613187113"},{"key":"34","unstructured":"H Pape, K Orth, A Heese, et al.  \"Eur J Med Res.\"  11, \"G-CSF during large field radiotherapy reduces bone marrow recovery capacity.\" 322 (2006)"},{"key":"35","doi-asserted-by":"crossref","unstructured":"AL Quartino, MO Karlsson, H Lindman, et al.  \"Pharm Res.\"  31, \"Characterization of endogenous G-CSF and the inverse correlation to chemotherapy-induced neutropenia in patients with breast cancer using population modeling.\" 3390 (2014)","DOI":"10.1007\/s11095-014-1429-9"},{"key":"36","doi-asserted-by":"crossref","unstructured":"S Saito, Y Kawano, T Watanabe, et al.  \"J Hematother.\"  8, \"Serum granulocyte colony-stimulating factor kinetics in children receiving intense chemotherapy with or without stem cell support.\" 291 (1999)","DOI":"10.1089\/106161299320325"},{"key":"37","doi-asserted-by":"crossref","unstructured":"H Takatani, H Soda, M Fukuda, et al.  \"Antimicrob Agents Chemother.\"  40, \"Levels of recombinant human granulocyte colony-stimulating factor in serum are inversely correlated with circulating neutrophil counts.\" 988 (1996)","DOI":"10.1128\/AAC.40.4.988"},{"key":"38","doi-asserted-by":"crossref","unstructured":"G Reisbach, T Kamp, G Welzl, et al.  \"Br J Haematol.\"  92, \"Regulated plasma levels of colony-stimulating factors, interleukin-6 and interleukin-10 in patients with acute leukaemia and non-hodgkin's lymphoma undergoing cytoreductive chemotherapy.\" 907 (1996)","DOI":"10.1046\/j.1365-2141.1996.434972.x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"SB Asegaonkar, BN Asegaonkar, UV Takalkar, et al.  \"Int J Breast Cancer.\"  2015, \"C-reactive protein and breast cancer: New insights from old molecule.\" 145647 (2015)","DOI":"10.1155\/2015\/145647"},{"key":"40","doi-asserted-by":"crossref","unstructured":"NR Sproston  and JJ Ashworth  \"Front Immunol.\"  9, \"Role of C-reactive protein at sites of inflammation and infection.\" 754 (2018)","DOI":"10.3389\/fimmu.2018.00754"}],"container-title":["Radiation Research"],"original-title":[],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T12:40:28Z","timestamp":1624970428000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/radiation-research\/volume-196\/issue-1\/RADE-20-00288.1\/Mitigation-of-Hematopoietic-Syndrome-of-Acute-Radiation-Syndrome-by-1\/10.1667\/RADE-20-00288.1.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,29]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1667\/rade-20-00288.1","relation":{},"ISSN":["0033-7587"],"issn-type":[{"value":"0033-7587","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,29]]}}}